by Cells4Life Middle East | Jun 10, 2025 | Cord Tissue Banking, Cord tissue stem cells, Stem Cell News
Cord tissue stem cell therapy is showing game-changing promise in a new clinical trial for children with epidermolysis bullosa (EB)—a rare, painful skin disorder that causes severe blistering and tearing. Early results from the MissionEB study suggest that stem cells...
by Cells4Life Middle East | Apr 28, 2025 | Stem Cell News
A stem cell trial performed in 2019 by doctors in Miami saw a child with autism speak his first full sentence within hours of receiving stem cell transplant. The stem cell treatment was given to an 11-year-old British boy named Danny Bullen, with the dramatic...
by Cells4Life Middle East | Mar 20, 2025 | Cord Blood Stem Cells, Stem Cell News
In a significant breakthrough for leukaemia treatment, the U.S. Food and Drug Administration (FDA) has recently approved the use of a CAR-T cell therapy derived from umbilical cord blood for clinical trials. This approval marks a major milestone as it is the...
by Cells4Life Middle East | Feb 18, 2025 | Cord Blood Banking, Cord Blood Stem Cells, Stem Cell News
In a heartwarming and miraculous turn of events, three-year-old Tommy Bacon is now in remission from a rare and aggressive form of leukaemia, thanks to the stem cells from his baby sister’s cord blood. Tommy’s story highlights the life-saving importance of cord blood...
by Cells4Life Middle East | Dec 12, 2024 | Cord Blood Stem Cells, Stem Cell News
A groundbreaking study published in The Lancet has revealed that stem cells derived from cord blood can significantly improve vision. This pioneering achievement, hailed as a world first, is bringing new hope to patients with sight-threatening conditions. The Focus:...
by Cells4Life Middle East | Nov 14, 2024 | Cord Blood Stem Cells, Stem Cell News
Recent advancements in stem cell research are revolutionizing our approach to critical health conditions, particularly in the field of acute liver failure (ALF). This life-threatening condition poses significant challenges due to limited treatment options. However,...
